XML 56 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation Arrangement Expenses Recognized
 
Years ended December 31,
(Dollars in thousands)
2014
 
2013
 
2012
Salaries, wages and employee benefits
$
20,035

 
$
20,783

 
$
14,464

Deferred income tax benefit
(7,673
)
 
(8,090
)
 
(5,616
)
Net share-based compensation expense
$
12,362

 
$
12,693

 
$
8,848

Summary Of Nonvested Stock Activity
 
Number of
Awards
 
Weighted-
Average
Grant-Date
Fair Value
Outstanding at December 31, 2013
823,070

 
$
32.15

Awarded – Employees
222,253

 
36.94

Awarded – Directors
22,480

 
44.47

Vested
(277,451
)
 
32.85

Forfeited
(19,274
)
 
33.75

Outstanding at December 31, 2014
771,078

 
$
33.60

Schedule of Nonvested Performance-based Units Activity
 
Number of
Awards
 
Weighted-
Average
Grant-Date
Fair Value
Outstanding at December 31, 2013
437,015

 
$
31.02

Awarded
205,667

 
36.47

Forfeited
(13,117
)
 
33.22

Outstanding at December 31, 2014
629,565

 
$
32.75

Summary Of Stock-Option Activity
 
Number of
Options
 
Weighted-
Average
Exercise
Price
 
Weighted-Average Remaining Contractual Term (years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2013
1,488,741

 
$
39.59

 
 
 
 
Exercised
(926,454
)
 
36.59

 
 
 
 
Expired or cancelled
(15,100
)
 
50.28

 
 
 
 
Outstanding at December 31, 2014
547,187

 
$
44.36

 
2.88
 
$
3,461

Exercisable at December 31, 2014
544,184

 
$
44.44

 
2.86
 
$
3,403

Schedule Of Share Based Compensation Stock Options Exercise Activity
(Dollars in thousands)
2014
 
2013
 
2012
Aggregate intrinsic value of exercised options
$
12,177

 
$
9,868

 
$
1,614

Cash received from exercise of options
33,902

 
20,777

 
3,560

Tax benefit realized from exercise of options
4,664

 
3,848

 
629

Summary Of Weighted-Average Assumptions Used In The Black-Scholes Option-Pricing Model
 
2012
Estimated fair value
$
11.79

Risk-free interest rate
0.7
%
Expected term (years)
4.91

Expected volatility
52
%
Expected dividend yield
1.37
%
Summary Of Stock Appreciation Rights
 
Number of
Rights
 
Weighted-
Average
Exercise Price
 
Weighted-Average Remaining Contractual Term (years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2013
283,221

 
$
28.92

 
 
 
 
Exercised
(175,990
)
 
28.92

 
 
 
 
Outstanding at December 31, 2014
107,231

 
$
28.92

 
5.11
 
$
2,173

Exercisable at December 31, 2014
107,231

 
$
28.92

 
5.11
 
$
2,173

Schedule Of Share Based Compensation Stock Options Exercise Activity SARS
(Dollars in thousands)
2014
 
2013
 
2012
Cash paid to settle exercised SARs
$
3,623

 
$
2,382

 
$
51

Realized tax benefit
1,388

 
929

 
20